Digital Treatment & Care - China | Statista Market Forecast

The Digital Treatment & Care market in China is expected to witness significant growth in the coming years.
According to projections, the revenue in this market is estimated to reach US$26.50bn by 2024.
Furthermore, it is anticipated that the market will experience a steady annual growth rate of 7.61% from 2024 to 2029, resulting in a projected market volume of US$38.24bn by the end of 2029.
In terms of user penetration, it is predicted that 30.07% of the population will be utilizing digital treatment and care services in 2024.
This figure is expected to rise to 41.10% by 2029, indicating a significant increase in the adoption of these services.
The average revenue per user (ARPU) is estimated to be US$61.53, highlighting the potential for substantial financial returns in this market.
When compared globally, it is worth noting that United States is expected to generate the highest revenue in the Digital Treatment & Care market, reaching US$29.91bn by 2024.
This demonstrates the strong market presence of the United States in this industry.
China is leading the way in the development and adoption of digital treatment and care solutions in the digital health market.

Definition:

The Digital Treatment & Care market includes devices and apps that help users monitor and analyze lifestyle-related aspects and improve their overall health. It includes user and revenue trends for four categories: digital care management, connected Biosensors, and online pharmacies.

Structure:

The Digital Treatment & Care market is divided into four markets:

Connected Biosensors: Biosensors that collect information on a variety of health parameters and vital signs of an individual (blood pressure, temperature, blood glucose, weight) by reading or measuring this data and transmitting it via electrical signals.

Digital Care Management: Various apps that help users monitor/detect/analyze physical health conditions. Contraception and fertility apps provide users with guidelines on self-care, family planning, and birth control, raise their awareness, and offer monitoring functions. Medication checker apps provide users with useful dosage intake guidelines, drug interaction information, and personal medication records.

Online Pharmacies: Over-the-counter medicine that can be purchased without a medical prescription through online sales channels. The market comprises analgesics, cold and cough medication, digestives and intestinal remedies, skin treatment products, and vitamins and minerals.

Digital Therapeutics (DTx): Software-based therapeutic interventions that deliver evidence-based therapeutic content to patients to prevent, manage, or treat a medical condition. DTx can be used to treat a wide range of conditions, including chronic diseases, mental health disorders, and substance use disorders.

Additional Information:

The digital care management user base includes paying and non-paying customers. The revenue figures only include revenues generated from paid apps offering premium options and from in-app purchases; revenues from app downloads and advertising are not included. The data only reflects B2C revenues; B2B and C2C revenues are not covered.

Contraception and fertility apps
Medication checker apps
Smart blood pressure meters
Smart thermometers
Smart glucose meters
Natural and synthetic agents
Analgesics (e.g., aspirin, paracetamol)
Cough and cold remedies (e.g., Vicks VapoRub)
Vitamins and minerals
Skin treatment products
Care phones/social alarms

Health tracking devices
Fitness apps
Sleeping apps
Mood improvement apps
Health tracking apps
Fitness wearables
Fitness apps
Motion trackers

The Digital Treatment & Care market in China is experiencing rapid growth and development, driven by various factors shaping consumer preferences and market trends.

Customer preferences: Chinese consumers are increasingly turning to digital solutions for their healthcare needs, seeking convenience, efficiency, and personalized experiences. The demand for digital treatment and care services such as contraception/fertility apps, medication checker apps, online pharmacies, smart health monitoring devices, and digital therapeutics is on the rise. Customers value the ability to access healthcare services remotely, receive real-time health insights, and manage their health conditions effectively through digital platforms.

Trends in the market: In China, there is a growing trend towards the adoption of digital health technologies and services. Contraception/fertility apps are gaining popularity among women who are looking for natural family planning methods or fertility tracking tools. Medication checker apps are being used to verify drug information, dosage, and potential interactions. Online pharmacies are becoming more prevalent, offering a wide range of healthcare products and medications for online purchase. Smart health monitoring devices such as thermometers, blood glucose meters, and blood pressure meters are being embraced by tech-savvy consumers for continuous health tracking. Additionally, digital therapeutics are being integrated into treatment plans for various chronic conditions, providing evidence-based interventions and support for patients.

Local special circumstances: China's large population, rapid urbanization, increasing healthcare expenditures, and advancements in technology are driving the growth of the Digital Treatment & Care market. The Chinese government is also actively promoting the development of digital healthcare solutions to address healthcare challenges, improve access to medical services, and enhance healthcare efficiency. Moreover, the tech-savvy nature of Chinese consumers and their willingness to adopt innovative healthcare technologies are contributing to the expansion of the digital treatment and care market in the country.

Underlying macroeconomic factors: The digital transformation of the healthcare sector in China is supported by favorable macroeconomic factors such as the increasing internet penetration, smartphone usage, and tech infrastructure. The rise of digital health startups, investments in healthcare technology, and collaborations between tech companies and healthcare providers are further fueling the growth of the Digital Treatment & Care market in China. Additionally, changing regulatory policies, shifting consumer behaviors, and the emphasis on preventive healthcare are shaping the landscape of digital treatment and care services in the country.

Data coverage:

The data encompasses B2C enterprises. Figures are based on revenues and user data of relevant mobile applications and consumer electronics companies.

Modeling approach / Market size:

Market sizes are determined through a combined top-down and bottom-up approach, building on a specific rationale for each market segment. As a basis for evaluating markets, we use annual financial reports of key players, industry reports, third-party reports, and survey results from primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as GDP, population, internet penetration, smartphone penetration, consumer spending, and healthcare spending. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, the S-curve function and exponential trend smoothing are well suited for forecasting digital products and services due to the non-linear growth of technology adoption.

Additional notes:

The market is updated twice a year in case market dynamics change. The impact of the COVID-19 pandemic and the Russia-Ukraine war is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Digital market, in a PDF format.